2X Match My Gift
Make a tax-deductible donation and double your impact to support colorectal cancer patients, survivors, and caregivers.
The Colorectal Cancer Alliance’s philanthropic research fund, Project Cure CRC, has announced another awardee. Yekaterina Zaytseva, PhD, of the University of Kentucky will receive $200,000 over two years.
Zaytseva, an assistant professor of toxicology and cancer biology, will accelerate science to end colorectal cancer by investigating new drug combinations that effectively kill colorectal cancer cells with a BRAF mutation. This condition currently has a low response rate to existing treatments.
With this funding, Zaytseva could help identify the best drug combinations to improve the survival of patients with BRAF mutant colorectal cancer, quickly translating these findings into clinical trials and new therapies that can become standard treatments.
The Alliance’s Project Cure CRC seeks to create major breakthroughs in colorectal cancer diagnosis, treatment, metastasis, and survivorship. Its goal is to provide $100 million to accelerate urgent research leading to cures.
“We are in a race against time to help the millions of Americans and their families affected by colorectal cancer,” says Michael Sapienza, CEO of the Colorectal Cancer Alliance. “We congratulate Yekaterina Zaytseva and look forward to her progress.”
Colorectal cancer is the nation’s second deadliest cancer, and the disease is on the rise in younger people. However, it remains less known and less funded than other cancers. This year, more than 150,000 people are expected to be diagnosed with the disease, and more than 50,000 could die.
The Alliance, the largest organization dedicated to ending colorectal cancer, invites the public, corporations, foundations, and philanthropic individuals to join our mission by contributing to Project Cure CRC. In addition, the Alliance seeks new ideas for mCRC research with special attention given to immunotherapy-based studies and research focused on BRCA1, BRAF, TP53, TME, and associated pathway genes.
For more information on Project Cure CRC, to donate, or to learn more about submitting a research proposal please visit colorectalcancer.org/research/research-investments/project-cure-crc.
Learn about The Cancer Promise initiative and how political candidates can pledge to support cancer research, prevention, and care policies. Make your voice heard this election.
This bipartisan legislation aims to improve participation in clinical trials by addressing major barriers such as non-medical expenses, trial location accessibility, diverse participation, and financial implications for patients.
The collaboration aims to raise awareness, encourage screening, and help people better understand their risks.